What We Do
Team
Collaborations & Studies
News & Publications
Contact
More
Optimising drug development, including improved clinical trial design and outcomes
Providing analytics that increase the responder rate & monitoring for cancer recurrence
Current collaborations and studies
Focusing on the human origin of RNA mutations relating to viral function and evolution
Early detection and better categorisation of the disease to assist in delaying onset
